3-bromo-5-chloro-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidine;3-bromo-5,7-dichloro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine;4-[3-bromo-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;morpholine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole

C68H78BBr3Cl3N17O7 — CID 158042447

IUPAC3-bromo-5-chloro-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidine;3-bromo-5,7-dichloro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine;4-[3-bromo-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;morpholine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole
SMILESBrc1cnn2c(-c3cccc4c3cnn4C3CCCCO3)cc(N3CCOCC3)nc12.C1COCCN1.CC1(C)OB(c2cccc3c2cnn3C2CCCCO2)OC1(C)C.ClC1CC(Cl)n2ncc(Br)c2N1.Clc1cc(-c2cccc3c2cnn3C2CCCCO2)n2ncc(Br)c2n1
InChIInChI=1S/C22H23BrN6O2.C18H25BN2O3.C18H15BrClN5O.C6H6BrCl2N3.C4H9NO/c23-17-14-25-29-19(12-20(26-22(17)29)27-7-10-30-11-8-27)15-4-3-5-18-16(15)13-24-28(18)21-6-1-2-9-31-21;1-17(2)18(3,4)24-19(23-17)14-8-7-9-15-13(14)12-20-21(15)16-10-5-6-11-22-16;19-13-10-22-25-15(8-16(20)23-18(13)25)11-4-3-5-14-12(11)9-21-24(14)17-6-1-2-7-26-17;7-3-2-10-12-5(9)1-4(8)11-6(3)12;1-3-6-4-2-5-1/h3-5,12-14,21H,1-2,6-11H2;7-9,12,16H,5-6,10-11H2,1-4H3;3-5,8-10,17H,1-2,6-7H2;2,4-5,11H,1H2;5H,1-4H2
InChIKeyFINAGRYFFQFTTB-UHFFFAOYSA-N
MW1602.37 g/mol
LogP14.31
Rot. Bonds7

About 3-bromo-5-chloro-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidine;3-bromo-5,7-dichloro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine;4-[3-bromo-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;morpholine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole

3-bromo-5-chloro-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidine;3-bromo-5,7-dichloro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine;4-[3-bromo-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;morpholine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole (PubChem CID 158042447) has the molecular formula C68H78BBr3Cl3N17O7 and a molecular weight of 1602.37 g/mol. Its IUPAC name is 3-bromo-5-chloro-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidine;3-bromo-5,7-dichloro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine;4-[3-bromo-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;morpholine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole.

Molecular Properties

Compound Name3-bromo-5-chloro-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidine;3-bromo-5,7-dichloro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine;4-[3-bromo-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;morpholine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole
PubChem CID158042447
Molecular FormulaC68H78BBr3Cl3N17O7
Molecular Weight1602.37 g/mol
Exact Mass1597.30
IUPAC Name3-bromo-5-chloro-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidine;3-bromo-5,7-dichloro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine;4-[3-bromo-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;morpholine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole
SMILESBrc1cnn2c(-c3cccc4c3cnn4C3CCCCO3)cc(N3CCOCC3)nc12.C1COCCN1.CC1(C)OB(c2cccc3c2cnn3C2CCCCO2)OC1(C)C.ClC1CC(Cl)n2ncc(Br)c2N1.Clc1cc(-c2cccc3c2cnn3C2CCCCO2)n2ncc(Br)c2n1
InChIInChI=1S/C22H23BrN6O2.C18H25BN2O3.C18H15BrClN5O.C6H6BrCl2N3.C4H9NO/c23-17-14-25-29-19(12-20(26-22(17)29)27-7-10-30-11-8-27)15-4-3-5-18-16(15)13-24-28(18)21-6-1-2-9-31-21;1-17(2)18(3,4)24-19(23-17)14-8-7-9-15-13(14)12-20-21(15)16-10-5-6-11-22-16;19-13-10-22-25-15(8-16(20)23-18(13)25)11-4-3-5-14-12(11)9-21-24(14)17-6-1-2-7-26-17;7-3-2-10-12-5(9)1-4(8)11-6(3)12;1-3-6-4-2-5-1/h3-5,12-14,21H,1-2,6-11H2;7-9,12,16H,5-6,10-11H2,1-4H3;3-5,8-10,17H,1-2,6-7H2;2,4-5,11H,1H2;5H,1-4H2
InChIKeyFINAGRYFFQFTTB-UHFFFAOYSA-N
XLogP14.31
TPSA223.57 Ų
H-Bond Donors2
H-Bond Acceptors24
Rotatable Bonds7
Heavy Atoms99
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001602.37
LogP ≤ 514.31
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'N-C-halo', 'substructure': 'N/A'}

Analyze 3-bromo-5-chloro-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidine;3-bromo-5,7-dichloro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine;4-[3-bromo-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;morpholine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-bromo-5-chloro-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidine;3-bromo-5,7-dichloro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine;4-[3-bromo-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;morpholine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole?
The IUPAC name of 3-bromo-5-chloro-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidine;3-bromo-5,7-dichloro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine;4-[3-bromo-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;morpholine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole (CID 158042447) is 3-bromo-5-chloro-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidine;3-bromo-5,7-dichloro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine;4-[3-bromo-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;morpholine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole.
What is the SMILES notation for 3-bromo-5-chloro-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidine;3-bromo-5,7-dichloro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine;4-[3-bromo-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;morpholine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole?
The canonical SMILES for 3-bromo-5-chloro-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidine;3-bromo-5,7-dichloro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine;4-[3-bromo-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;morpholine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole is Brc1cnn2c(-c3cccc4c3cnn4C3CCCCO3)cc(N3CCOCC3)nc12.C1COCCN1.CC1(C)OB(c2cccc3c2cnn3C2CCCCO2)OC1(C)C.ClC1CC(Cl)n2ncc(Br)c2N1.Clc1cc(-c2cccc3c2cnn3C2CCCCO2)n2ncc(Br)c2n1.
What is the InChIKey of 3-bromo-5-chloro-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidine;3-bromo-5,7-dichloro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine;4-[3-bromo-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;morpholine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole?
The InChIKey is FINAGRYFFQFTTB-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H23BrN6O2.C18H25BN2O3.C18H15BrClN5O.C6H6BrCl2N3.C4H9NO/c23-17-14-25-29-19(12-20(26-22(17)29)27-7-10-30-11-8-27)15-4-3-5-18-16(15)13-24-28(18)21-6-1-2-9-31-21;1-17(2)18(3,4)24-19(23-17)14-8-7-9-15-13(14)12-20-21(15)16-10-5-6-11-22-16;19-13-10-22-25-15(8-16(20)23-18(13)25)11-4-3-5-14-12(11)9-21-24(14)17-6-1-2-7-26-17;7-3-2-10-12-5(9)1-4(8)11-6(3)12;1-3-6-4-2-5-1/h3-5,12-14,21H,1-2,6-11H2;7-9,12,16H,5-6,10-11H2,1-4H3;3-5,8-10,17H,1-2,6-7H2;2,4-5,11H,1H2;5H,1-4H2.
What are the key properties of 3-bromo-5-chloro-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidine;3-bromo-5,7-dichloro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine;4-[3-bromo-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;morpholine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole?
3-bromo-5-chloro-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidine;3-bromo-5,7-dichloro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine;4-[3-bromo-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;morpholine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole has a molecular weight of 1602.37 g/mol, XLogP of 14.31, 7 rotatable bonds, 2 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 3-bromo-5-chloro-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidine;3-bromo-5,7-dichloro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine;4-[3-bromo-7-[1-(oxan-2-yl)indazol-4-yl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine;morpholine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole is sourced from PubChem (CID 158042447), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).